✦ LIBER ✦

A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: The AFR-15 trial

✍ Scribed by Patrice Chevallier; Mathilde Hunault-Berger; Fabrice Larosa; Charles Dauriac; Richard Garand; Jean-Luc Harousseau

Book ID: 104040861
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 101 KB
Volume: 33
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2008.09.030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a multicenter phase II trial

Results of a multicenter phase II trial for older patients with c-Kit-positive acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS) using low-dose Ara-C and Imatinib

✍ Florian Heidel; Jorge Cortes; Frank G. Rücker; Walter Aulitzky; Laurie Letvak; T 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views